flagyl-metronidazole500mg[.]com

This domain, flagyl-metronidazole500mg.com, is flagged as an elevated-risk credential theft operation targeting users through deceptive login portals. Analysis indicates the site impersonates legitimate pharmaceutical services to harvest account credentials, payment details, or personal data under false pretenses. The threat type aligns with credential harvesting rather than generic phishing, as evidenced by its infrastructure and detection patterns. Infrastructure analysis reveals multiple high-risk indicators. The domain was registered on July 28, 2025, through Fewmoretaps OÜ d/b/a Trustname.com, a registrar frequently associated with malicious domains. It resolves to IP address 3.71.180.249, which has been linked to prior phishing campaigns. Detection metrics include 7/95 security vendors flagging the domain on VirusTotal, a Gridinsoft trust score of 0/100, and a Scamadviser trust score of 20/100. The domain appears on one security blocklist and is referenced in one AlienVault OTX threat intelligence pulse. Technologies detected include DDoS-Guard, a service often exploited to obscure malicious infrastructure. Mitigation steps for credential theft threats include immediate domain blocking at the network level, particularly for endpoints resolving to 3.71.180.249. Organizations should deploy email filtering rules to quarantine messages containing the domain or its subcomponents. Users should be advised to avoid entering credentials on untrusted sites, even if they mimic legitimate services. Multi-factor authentication (MFA) should be enforced for all accounts to reduce the impact of stolen credentials. Security teams are advised to monitor for lateral movement or unauthorized access attempts following exposure to this domain.